Are there generic versions of bimetinib/bemetinib?

Binimetinib/Binimetinib is an oral drug that targets MEK1/2 and is mainly used to treat specific types of cancer such as melanoma and non-small cell lung cancer. Since it is marketed and approved in many overseas countries, it has received widespread attention in anti-tumor treatment.

Bimetinib inhibits the activity ofMEK1/2 and effectively reduces the activation of MEK-dependent effector proteins and transcription factors, thereby blocking growth factor-mediated cell signaling and inhibiting tumor cell proliferation. In addition, it can inhibit the production of a variety of inflammatory cytokines, including interleukin-1, interleukin-6, and tumor necrosis factor, which further enhances its anti-tumor effect in the tumor microenvironment.

Although the original drug bimetinib has performed well in foreign markets, it has not yet been launched in China. Therefore, domestic patients cannot purchase this drug directly. However, according to the latest news, generic drugs of bimetinib are currently being produced and sold, and the manufacturer is Lucius Pharmaceuticals in Laos. The ingredients of the generic drug are basically the same as the original drug, but there may be some differences in production specifications and price.

In terms of price, the European version of bimetinib’s original drug is commonly packaged in 84 and 168 15mg tabletsThe price per box is about 20,000 yuan (the specific price will fluctuate due to exchange rate changes). In comparison, the price of generic drugs is more affordable. For example, the price of generic bimetinib in 15mg*180 tablets is more than 6,000 yuan per box (again, the price may fluctuate due to exchange rates). This price difference allows more patients to have access to treatment.

Reference materials:https://en.wikipedia.org/wiki/Binimetinib